No Data
No Data
Over 50% of the Nasdaq-100 Names Trade Below Their 200-day Moving Average
Jim Cramer: This Energy Stock Is A Buy, Stay Away From DexCom
Dexcom (DXCM) Receives a Buy From Wells Fargo
Abbott to Integrate CGM System With Medtronic's Insulin Delivery Devices
Down 40% in 1 Day, Is DexCom Stock Still a Buy?
Express News | Dexcom Inc : Baird Raises Target Price to $82 From $80
No Data